| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/02/2010 | US7671253 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
| 03/02/2010 | US7671252 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 03/02/2010 | US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes |
| 03/02/2010 | US7671190 Transformed host cells that make the anticancer polyketides herbimycin and geldanamycin; biosynthesis |
| 03/02/2010 | US7671189 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 03/02/2010 | US7671188 Cellulose synthase from pine and methods of use |
| 03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
| 03/02/2010 | US7671181 Protozoan serine/threonine kinase for identifying modulators for use in targeted destruction tumor cells; veterinary medicine |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671179 Substituting an amino acid within the variable domain of the heavy or light chain of the monoclonal antibody wherein above amino acid containing a nonpolar side chain, with a proline |
| 03/02/2010 | US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 03/02/2010 | US7671174 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR) |
| 03/02/2010 | US7671036 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/02/2010 | US7671035 Epidermal growth factor receptor antisense oligonucleotides |
| 03/02/2010 | US7670932 MOS structures with contact projections for lower contact resistance and methods for fabricating the same |
| 03/02/2010 | US7670835 diagnosis of and vaccination against Streptococcal infections ; detection of virulence markers of Streptococci |
| 03/02/2010 | US7670832 System for fluorescence monitoring |
| 03/02/2010 | US7670831 Detects various target biomaterials that bind or react with the bioreceptors by precisely measuring directly or by electrochemical signals at large amounts in one step |
| 03/02/2010 | US7670829 from a simple carbon source; includes 17 alpha -hydroxypregnenolone, cortisol, cortexolone, 17 alpha -hydroxyprogesterone, and derivatives; genetic engineering |
| 03/02/2010 | US7670828 Expression vector comprising nucleotide sequences coding genes associated with alcohol fermentation; for generating transgenic saccharomyces; improving productivity and/or flavor of alcoholic beverages |
| 03/02/2010 | US7670827 Strain belonging to the genus Streptomyces and being capable of producing nemadictin and process for producing nemadictin using the strain |
| 03/02/2010 | US7670826 Belonging to subfamily of human immunoglobulin superfamily; isolated antibodies and nucleic acids; transformed host cells; modulating transendothelial migration of leukocytes; inflammation, tumors |
| 03/02/2010 | US7670825 Method for enhancing production of isoprenoid compounds |
| 03/02/2010 | US7670824 Multicopy-integration of heterologous genes and expression in Methylobacterium |
| 03/02/2010 | US7670823 Compositions for use in recombinational cloning of nucleic acids |
| 03/02/2010 | US7670820 genetic engineered polypeptide or isolated nucleic acid encoding the polypeptides, for degrading, breaking the cell wall of a fungus or a bacterium containing chitin; use as fungicides, bactericides, control plant pathogens; foods, cosmetics; transgenic plants resistant to plant diseases |
| 03/02/2010 | US7670819 Can be used in the conversion of cellulosic materials to monosaccharides, disaccharides, and polysaccharides; vectors, and host cells |
| 03/02/2010 | US7670818 β-mannanase from coffee berry borer, hypothenemus hampei, and uses thereof |
| 03/02/2010 | US7670816 UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1 |
| 03/02/2010 | US7670815 useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation |
| 03/02/2010 | US7670812 Using thermostable glucanotransferase to convert alpha glucans to glycogens |
| 03/02/2010 | US7670809 Using mutase as genetic engineering tool which generates modified polypeptides; proteomics and phenotype analysis |
| 03/02/2010 | US7670808 Nucleic acid modifying enzymes |
| 03/02/2010 | US7670806 Catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose by contacting with an isolated ARH3 polypeptide; modifying DNA repair or chromatin structure by modifying ARH3 polypeptide activity; drug screening; antiinflammatory, antiischemic agents; aging resistance |
| 03/02/2010 | US7670803 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma |
| 03/02/2010 | US7670802 CXC-chemokine antagonists isolated from Rhipicephalus sanguineus |
| 03/02/2010 | US7670801 Using immunoglobulins to isolate heterologous polypeptide fusion comprising viral coat sequences in adenoviral protein expression systems of plants, animals and bacteria |
| 03/02/2010 | US7670787 Protein forming complex with c-Fos protein, nucleic acid encoding the same and method of using the same |
| 03/02/2010 | US7670781 Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal |
| 03/02/2010 | US7670771 Assessing human predisposition to a febrile seizure disorder |
| 03/02/2010 | US7670770 comprising surface having a plurality of channels having a trench width of less than about 150 nanometers and depth of less than 200 nanometers |
| 03/02/2010 | US7670769 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 03/02/2010 | US7670767 Genetic alterations associated with cancer |
| 03/02/2010 | US7670766 Early detection of flaviviruses using the NS1 glycoprotein |
| 03/02/2010 | US7670611 Cancer immunotherapy with semi-allogeneic cells |
| 03/02/2010 | US7670610 Recombinant BCG vaccine |
| 03/02/2010 | US7670603 Using toll-like receptor polypeptides to generate atibodies for use in treatment and prevention of septic shock, inflammation and viral infection |
| 03/02/2010 | US7670602 Concatameric immunoadhesion molecule |
| 03/02/2010 | US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | US7670597 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 03/02/2010 | CA2478969C Early inflorescence-preferred regulatory elements and uses thereof |
| 03/02/2010 | CA2390659C Ny-eso-1 peptide derivatives, and uses thereof |
| 03/02/2010 | CA2314429C Insect-resistant transgenic plants and methods for improving .delta.-endotoxin activity against target insects |
| 03/02/2010 | CA2268753C Nucleic acid primers and probes for detecting oncogenic human papillomaviruses |
| 03/02/2010 | CA2190359C Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 03/02/2010 | CA2140894C Modified fungal cells and method for producing recombinant products |
| 03/01/2010 | CA2734807A1 Nematode-resistant transgenic plants |
| 02/25/2010 | WO2010022395A2 Methods of reprogramming cells |
| 02/25/2010 | WO2010022195A2 Non-integrating lenti/adeno-associated virus hybrid vector system |
| 02/25/2010 | WO2010022194A2 Compositions and methods for generation of pluripotent stem cells |
| 02/25/2010 | WO2010022186A1 Production of cellulase enzymes in plant hosts using transient agroinfiltration |
| 02/25/2010 | WO2010022145A2 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function |
| 02/25/2010 | WO2010022139A1 Regulation of integrin surface expression |
| 02/25/2010 | WO2010022098A2 Dna methylation detection methods |
| 02/25/2010 | WO2010021961A2 Improved production of proteins with downstream box fusions in plastids and in bacteria |
| 02/25/2010 | WO2010021868A2 Improvement of nitrogen responsiveness in plants |
| 02/25/2010 | WO2010021849A2 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae |
| 02/25/2010 | WO2010021846A2 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae |
| 02/25/2010 | WO2010021798A1 Improved crop stress tolerance, yield and quality via glutaredoxin overexpression |
| 02/25/2010 | WO2010021415A1 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 02/25/2010 | WO2010021396A1 Method for quantification or detection of dna |
| 02/25/2010 | WO2010021394A1 Method for quantification or detection of dna |
| 02/25/2010 | WO2010021392A1 In vitro fluorescence observation method for mammal embryo, and method for selecting mammal embryo reduced in risk of implantation failure or abortion |
| 02/25/2010 | WO2010021390A1 ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION |
| 02/25/2010 | WO2010021389A1 Nucleic acid capable of inhibiting expression of bcl-2 protein |
| 02/25/2010 | WO2010021375A1 Process for production of protease, protease solution, and solution of pro-form of protease |
| 02/25/2010 | WO2010021369A1 Method for detecting functional mold, method for evaluating functional mold-containing product and primer pair |
| 02/25/2010 | WO2010021344A1 Novel nucleic acid derivative, and method for preparing nuclease-resistant nucleic acid by using same |
| 02/25/2010 | WO2010021112A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 02/25/2010 | WO2010021111A1 Inhbb epitope peptides and vaccines containing the same |
| 02/25/2010 | WO2010021092A1 Method for testing on risk of metabolic syndrome or cardiovascular disease, and kit for risk test |
| 02/25/2010 | WO2010020868A2 Increasing cell wall deposition and biomass in plants |
| 02/25/2010 | WO2010020811A1 Non-cytotoxic fusion proteins comprising egf muteins |
| 02/25/2010 | WO2010020777A2 Protein expression |
| 02/25/2010 | WO2010020694A1 Polynucleotides which down-regulate the expression of the sbi protein |
| 02/25/2010 | WO2010020682A1 Production of n-acylated sulphur-containing amino acids with microorganisms having enhanced n-acyltransferase enzymatic activity |
| 02/25/2010 | WO2010020677A2 Protein c variants |
| 02/25/2010 | WO2010020654A2 Plants with increased yield by increasing or generating one or more activities in a plant or a part thereof |
| 02/25/2010 | WO2010020642A1 Stxbp1 as psychiatric biomarker in murine model system and their uses |
| 02/25/2010 | WO2010020555A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/25/2010 | WO2010020552A1 Transgenic plants comprising as transgene a phosphatidate cytidylyltransferase |
| 02/25/2010 | WO2010020494A1 Novel, universally applicable addition system |
| 02/25/2010 | WO2010020289A1 Production of n-acetylated sulphur-containing amino acids with microorganisms having enhanced n-acetyltransferase enzymatic activity |
| 02/25/2010 | WO2010020143A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 02/25/2010 | WO2010019996A1 Seed active transcriptional control sequences |
| 02/25/2010 | WO2010003108A3 TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 02/25/2010 | WO2009151697A3 Compositions and processes relating to human bocavirus |
| 02/25/2010 | WO2009147180A3 Microbicidal peptides of trichoderma reesei |
| 02/25/2010 | WO2009143446A3 Lambdasa2 endolysin truncation |